SCEJ

$B2=3X9)3X2qBh(B87$BG/2q(B($B?@8M(B)

$B9V1i?=$79~$_0lMw!J%7%s%]%8%&%`!&9V1iJ,N`JL!K(B

7) $B%P%$%*(B

7-e. $B%a%G%#%+%k(B

$B:G=*99?7F|;~!'(B2022-06-14 16:59:01

$B$3$NJ,N`$G$h$/;H$o$l(B
$B$F$$$k%-!<%o!<%I(B		$B%-!<%o!<%I(B$B
Image analysis3$B7o(B*
Laboratory automation3$B7o(B*
Cancer cells2$B7o(B
Biomaterial2$B7o(B
hydrogel2$B7o(B
mesenchymal stem cell2$B7o(B
drug delivery1$B7o(B

$B$BHV9f(B$B9V1iBjL\!?H/I=$B%-!<%o!<%I(B$BH/I=7A<0(B
8$B$,$s:YK&FbIt$G<+8JAH?%2=$7%"%]%H!<%7%9;`$r0z$-5/$3$9%Z%W%A%I;i
(Kobe U.) ($B@5(B)$B!{?9ED(B $B7rB@(B$B!&(B $B@>B<(B $B9a2;(B$B!&(B ($B3X(B)$B;3K\(B $BfFB@(B$B!&(B ($B3X(B)$B@6?e(B $B$J$D$_(B$B!&(B $B@D0f(B $B5.G7(B$B!&(B $BEDB<(B $B8|IW(B$B!&(B ($B@5(B)$B4];3(B $BC#@8(B		peptide lipid
self-assembly
cancer
P
17$B%A%m%7%s4^M-%Z%W%A%I;i
($B?@8MBg1!9)(B) ($B3X(B)$B!{@6?e(B $B$J$D$_(B$B!&(B ($B3X(B)$B6b8w(B $B:L@c(B$B!&(B $BH,Be(B $BJ~;R(B$B!&(B ($B@5(B)$B?9ED(B $B7rB@(B$B!&(B ($B@5(B)$B4];3(B $BC#@8(B		cancer cells
peptides
tyrosine kinase
P
76$B7PHiKc?lLt$K$*$1$k?<6&>=8=>]$NMxMQ(B
($BF1;V$B!&(B $BCf@n(B $BM:B@(B$B!&(B ($B@5(B)$B>>K\(B $BF;L@(B		Deep eutectic mixture
Topical anesthesia
Transdermal delivery
O
209Development of a Novel Chitosan-based Hydrogel as a Tissue Adhesive
($BElBg1!9)(B) ($B3X(B)$B!{hq(B $B7J>g(B$B!&(B ($B3X(B)Athira Sreedevi Madhavikutty$B!&(B ($BElBg1!0e(B) ($B@5(B)Arvind Kumar Singh Chandel$B!&(B ($BElBg1!0e(B/$BElBg1!9)(B) ($B@5(B)$B0KF#(B $BBgCN(B		tissue adhesive
chitosan hydrogel
pH-sensitive self-crosslinking
P
254$BFs=E4IO"7k%G%P%$%9$rMQ$$$?7l4ILOJo%3%i!<%2%s%^%$%/%m%A%e!<%V$N:n@=(B
($B@iMUBg1!9)(B) ($B3X(B)$B!{Lb;3(B $B4SB@(B$B!&(B ($B3X(B)$B9bLZ(B $B??0T(B$B!&(B $BL*ED(B $BBg2m(B$B!&(B ($B@5(B)$B;3ED(B $B??@!(B$B!&(B $B1-F,(B $BM}7C(B$B!&(B ($B@5(B)$B4X(B $B		Collagen
Vascular tissue
Microfluidic device
P
296$B?@7P:YK&(B1$B:YK&5!G=2r@O$N$?$a$NH/2P%Q%?!<%sDjNL2r@O(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{5WED(B $BBs3$(B$B!&(B ($BEl5~;|7C2q0eBg(B) $B?9Eg(B $BH~3(;R(B$B!&(B ($BL>Bg1!AOLt(B) ($B@5(B)$B3*9>(B $B7E(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Neuron
Firing pattern
Single cell analysis
P
298$B6a@V308w$rMQ$$$?$,$s%9%U%'%m%$%I%b%G%kI>2A(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{NS(B $B:i4u(B$B!&(B $B1J0f(B $BH~4u(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B ($B=;M'EE9)(B) $B8^==Mr(B $BM[;R(B$B!&(B $B?{>B(B $B42(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Cancer spheroid
Near-infrared light
Image analysis
P
299$BL~CeKI;_:`NA@_7W$N$?$a$N:YK&FC0[E*@\Ce8=>]I>2A%W%i%C%H%U%)!<%`$N9=C[(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{Az8EED(B $B0lM%(B$B!&(B ($B3X(B)$B?y;3(B $B0!LpEM(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B ($BL>Bg1!9)(B) $B86(B $B8w@8(B$B!&(B (NIMS) $B1'ET(B $B9C0lO:(B$B!&(B $B1A86(B $B=<9((B$B!&(B ($BL>Bg1!0e(B) $B=oJ}(B $BMu2N(B$B!&(B $B@.ED(B $BM5;J(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Biomaterial
Laboratory automation
Image analysis
P
30196$B%&%'%k%W%l!<%H$K$*$1$k:YK&6Q0lGEr7o$N:GE,2=(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{:d(B $B>-@.(B$B!&(B $B:#0f(B $BM4B@(B$B!&(B $B1|B<(B $BM4EM(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Laboratory automation
Cell seeding
Image analysis
P
304$B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{?y;3(B $B0!LpEM(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B ($B3X(B)$BAz8EED(B $B0lM%(B$B!&(B (NIMS) $B1'ET(B $B9C0lO:(B$B!&(B ($BL>Bg1!0e(B) $B=oJ}(B $BMu2N(B$B!&(B (NIMS) $B1A86(B $B=<9((B$B!&(B ($BL>Bg1!0e(B) $B@.ED(B $BM5;J(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Biomaterial
High content analysis
Laboratory automation
P
325$BJ"KlGE
($BElBg1!9)(B) ($B3X(B)$B!{>>ED(B $B97Bg(B$B!&(B ($B@5(B)$BB@ED(B $B@?0l(B$B!&(B ($BElBg1!0e(B/$BElBg1!9)(B) ($B@5(B)$B0KF#(B $BBgCN(B		drug delivery
mathematical model
peritoneal dissemination
P
329$B%b%A!<%UO"7k7??M9)
($B0eLt7r1I8&(B) ($B@5(B)$B!{2O86(B $B@59@(B$B!&(B $BCfEh(B $B63;R(B		chimeric receptor
tyrosine motif
signal transduction
O
348Development and Functional Evaluation of a Miniature Liver Model
(Kyushu U.) ($B3X(B)$B!{(BUehara Uyeda Mario Kokichi$B!&(B Wu Fanqi$B!&(B Fukuda Yukako$B!&(B ($B@5(B)Sakai Yusuke$B!&(B Shirakigawa Nana$B!&(B (Kumamoto U.) Miyata Tatsunori$B!&(B Nakao Yosuke$B!&(B Yamao Takanobu$B!&(B (Saga U.) Aishima Shinichi$B!&(B (Kumamoto U.) Yamashita Yo-ichi$B!&(B Baba Hideo$B!&(B (Kyushu U.) ($B@5(B)Ijima Hiroyuki		Decellularized Liver
Primary Human Hepatocyte
Cell Distribution
P
352$B7PHi%^%i%j%"%o%/%A%s$N3+H/$*$h$S7PHiEjM?$K$h$kLH1V1~Ez2r@O(B
($B6eBg1!9)(B) ($B3X(B)$B!{EDCf(B $B7IM$(B$B!&(B ($B@5(B)$BFnH*(B $B9'2p(B$B!&(B ($B@5(B)$B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		Transdermal vaccine delivery
Malaria
Immunology
P
375$B:YK&7ABV>pJs$rMQ$$$?G]CO8r49%G%6%$%s%9%Z!<%9$NM}2r(B
($BL>Bg1!AOLt(B) ($B3X(B)$B!{?$B!&(B $BC]K\(B $BM*?M(B$B!&(B $B0KF#(B $BM':H(B$B!&(B ($B3X(B)$B5WED(B $BBs3$(B$B!&(B ($B@5(B)$B3*9>(B $B7E(B$B!&(B($BL>Bg1!AOLt(B/$BL>Bg%J%N%i%$%U%7%9%F%`8&(B) ($B@5(B)$B2CF#(B $BN5;J(B		Mesenchymal Stem Cell
Quality by Design
Medium change
P
396$B9ZAGH?1~$rMxMQ$7$?9bJ,;R!&D6J,;R%O%$%V%j%C%I%2%k$NAO@=$H5!G=2=(B
($B6eBg1!9)(B) ($B3X(B)$B!{Hu8}(B $B0!LiEM(B$B!&(B ($B@5(B)$B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B		hybrid-gel
enzymatic-reaction
functionalization
P
402Balance of anti-peritoneal adhesion, hemostasis, and operability of compressed bi-layer ultrapure alginate sponges
(U. Tokyo) ($B3X(B)$B!{(BDai Yizhou$B!&(B ($B@5(B)Kumar Singh Chandel Arvind$B!&(B Yoshida Hiromi$B!&(B Nakamichi Akiko$B!&(B Taniguchi Machiko$B!&(B ($B@5(B)Ohta Seiichi$B!&(B (U. Tokyo/U. Tokyo Hospital) ($B@5(B)Ito Taichi		Adhesion barrier
Hemostat
Sponge
P
424$B9ZAG2M66@-%"%k%V%_%s%2%k2=:^$N3+H/$H:YK&Jq3g$X$N1~MQ(B
($B:4@$J]9b@l(B) ($B@5(B)$B!{?9;3(B $B9,M4(B$B!&(B ($B3X(B)$B0f85(B $BG53((B$B!&(B ($BD92,5;2JBg(B) $BFsIS(B $B>-D*(B$B!&(B $B:4F#(B $BH~6k(B$B!&(B $B:4F#(B $BIp;K(B$B!&(B ($B6eBg1!9)(B) ($B@5(B)$B8eF#(B $B2m9((B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B		hydrogel
albumin
enzyme
P
514$B;ih8z2L(B
($B6eBg1!9)(B) Pugoh Santoso$B!&(B ($B@5(B)$B!{FnH*(B $B9'2p(B$B!&(B ($BN0BgG@(B) $B@PNf(B $BM*8g(B$B!&(B ($B6eBg1!9)(B) ($B3X(B)$BC+8}(B $B9@@?(B$B!&(B ($B3X(B)$B:4F#(B $BVE(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B$B!&(B ($BN0BgG@(B) $B|bEg(B $BCRLi(B$B!&(B $BJ?NI(B $BEl5*(B$B!&(B ($B6eBg1!9)(B) ($B@5(B)$B?@C+(B $BE5Jf(B		Chitinase
Lipidation
Antifungal activity
O
560$B%U%#%k%`4pHW(BC2C12$B6ZAH?%$rMQ$$$?%+%j%&%`$N1F6A(B
($BBg9)Bg@8L?9)(B) ($B3X(B)$B!{4]LS(B $BM[B@(B$B!&(B ($BBg9)Bg1!9)@8L?9)(B) ($B3X(B)$B2O>e(B $BMZF`(B$B!&(B $B2E1Y(B $BM&B@(B$B!&(B ($B@5(B)$BD9?9(B $B1QFs(B$B!&(B ($B@5(B)$B:j;3(B $BN<0l(B		C2C12
Muscle atrophy
potassium
P
579$B7V8wLH1V%;%s%5!<(BCoiled Quenchbody$B$N$,$s8w@~NO3XNEK!$X$N1~MQ(B
(Tokyo Tech) ($B3X(B)$B!{DX(B $Bt%2L(B$B!&(B ($B3X(B)$B0BED(B $B5.?.(B$B!&(B ($B@5(B)$B$B!&(B $BKL8}(B $BE/Li(B$B!&(B ($B@5(B)$B>eED(B $B9((B		antibody
Coiled Quenchbody
Photodynamic Therapy
P
609$B%*!<%H%/%l!<%VLG6]$K$h$jD4@=$5$l$k%-%H%5%s%2%k$N3+H/(B
($B$B!&(B ($B@5(B)$BBg3Q(B $B5A9@(B$B!&(B ($B@5(B)$B5HED(B $B>;90(B$B!&(B ($B@5(B)$BIp0f(B $B9'9T(B		chitosan
hydrogel
autoclaving
P
612$B@8BNE,9g@-%$%*%s1UBN1U>=%-%c%j%"$rMQ$$$?7PHi5[<}@=:^$N3+H/(B
($B6eBg1!9)(B) ($B3X(B)$B!{86(B $B9>4u(B$B!&(B ($B@5(B)$B?@C+(B $BE5Jf(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		Drug Delivery System
Ionic Liquid
Liquid Crystal
P
613$B;@AGG;EY$N0c$$$,G]M\9|3J6Z:YK&$KM?$($k1F6A(B
($BL>Bg1!9)(B) ($B3X(B)$B!{M-K\(B $B2CF`3((B$B!&(B ($B@5(B)$B=);3(B $BM5OB(B$B!&(B ($B@5(B)$BK\B?(B $BM5G7(B$B!&(B ($B@5(B)$B@6?e(B $B0l7{(B		Skeletal muscle cells
Oxygen concentration
Differentiation
P
633$B46@w>IM=KI$rL\E*$H$7$?Cm
($B6eBg1!9)(B) ($B3X(B)$B!{8EED(B $B??M}(B$B!&(B ($B3X(B)$B>.:d(B $B=(EM(B$B!&(B ($B@5(B)$B8eF#(B $B2m9((B		transdermal
vaccine
patch
P
647miRNA$B%Q%M%k$rMQ$$$?(BCAR-T$B:YK&NEK!$N%3%s%Q%K%*%s?GCG%b%G%k$N3+H/(B
($BElBg9)(B) ($B3X(B)$B!{zpED(B $BM|=m(B$B!&(B ($BElBg1!9)(B) ($B@5(B)$BCfB<(B $BG5M};R(B$B!&(B ($B0&CN$,$s%;(B) $BdFC+(B $BM&5*(B$B!&(B ($BL@<#BgM}9)(B) ($B@5(B)$B6b;R(B $B90>;(B$B!&(B ($BElBg1!9)(B/JST$B$5$-$,$1(B) ($B@5(B)$BB@ED(B $B@?0l(B		companion diagnostics
miRNA
CAR-T cell therapy
P
657$B:YK&@\Ce%Z%W%A%I=$>~B?9&
($BElBg1!9)(B) ($B3X(B)$B!{Ln4V(B $B1_(B$B!&(B ($B3X(B)$BBgLZ(B $BM*0lO/(B$B!&(B ($B002=@.(B) ($BK!(B)$B86G<(B $B90Bg(B$B!&(B ($BK!(B)$BB<2,(B $B8,(B$B!&(B ($BK!(B)$B86(B $BM:0l(B$B!&(B ($BElBg1!9)(B) ($B@5(B)$B0KF#(B $BBgCN(B		mesenchymal stem cell
microcarrier
RGD
P
669$B$,$s:YK&M7AvAK32$K8~$1$?(BEWI-2$BM3Mh%F%H%i%9%Q%K%s(BCD81$B7k9g@-%Z%W%A%I$NC5:w(B
($BEl9)Bg(B) ($B3X(B)$B!{Gv>l(B $B7=(B$B!&(B $B%9%o%C%?%J!<%i%C%H(B $B%?%J%o%C%H(B$B!&(B ($B@5(B)$BEDCf(B $BM47=(B$B!&(B ($B@5(B)$BBg2OFb(B $BH~F`(B		CD81 protein
Peptide
Cancer cells
P
699$B%^%$%/%m%W%i%9%A%C%/$N?MBN1F6AI>2A(B
($BElBg1!9)(B) ($B3X(B)$B!{NkLZ(B $BM%@5(B$B!&(B ($B@5(B)$B0pB<(B $B91N<(B$B!&(B ($B3$(B)$B%@%N%"(B $B%^%7%e!<(B$B!&(B ($B@5(B)$B@>@n(B $B>;51(B$B!&(B ($B@5(B)$B		microplastic
in vitro
toxicity
P
$B9V1i?=$79~$_0lMw(B($B%7%s%]%8%&%`HV9f!&9V1iJ,N`HV9fJL(B)
$B
$B2=3X9)3X2qBh(B87$BG/2q(B($B?@8M(B)
(C) 2022 $B8x1W
Most recent update: 2022-06-14 16:59:01
For more information contact $B2=3X9)3X2qBh(B87$BG/2q
E-mail: inquiry-87awww3.scej.org
This page was generated by easp 2.47; update.pl 2.37 (C)1999-2015 kawase